SFTPB and acute respiratory distress syndrome: These earlier results, coupled with the surface and physiological activity data found here for S-MB and MB surfactants, strongly support the use of SP-B-related peptides in synthetic lipid/peptide exogenous surfactants for treating lung surfactant deficiency (NRDS) or injury-induced dysfunction (ALI/ARDS).